These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1624396)

  • 41. Penetration of pefloxacin into bronchial secretions.
    Bonmarchand G; Grès JJ; Lerebours G; Massari P; Mayoux JJ; Montay A; Leroy J
    Antimicrob Agents Chemother; 1989 Mar; 33(3):391-3. PubMed ID: 2729932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic data in gynecological surgery using preoperative augmentin.
    Von Kobyletzki V
    Chemioterapia; 1987 Jun; 6(2 Suppl):262-4. PubMed ID: 3509406
    [No Abstract]   [Full Text] [Related]  

  • 43. [Vaginal absorption of neomycin; research on the antibiotic in uterine portio, myometrium, fallopian tubes and the ovary].
    ALAMANNI V
    Riv Ostet Ginecol Prat; 1956 Aug; 38(8):680-701. PubMed ID: 13380312
    [No Abstract]   [Full Text] [Related]  

  • 44. Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits.
    Marrakchi-Benjaafar S; Cochereau I; D'Hermies F; Pocidalo JJ
    Antimicrob Agents Chemother; 1995 Apr; 39(4):834-8. PubMed ID: 7785980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of subchronic malathion exposure on the pharmacokinetic disposition of pefloxacin.
    Suresh Babu N; Malik JK; Rao GS; Aggarwal M; Ranganathan V
    Environ Toxicol Pharmacol; 2006 Sep; 22(2):167-71. PubMed ID: 21783705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penetration of fleroxacin into body tissues and fluids.
    Weidekamm E; Portmann R
    Am J Med; 1993 Mar; 94(3A):75S-80S. PubMed ID: 8452186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of ceftriaxone in serum and gynecological tissues.
    De Grandi P; Bauen JF
    Chemotherapy; 1986; 32(6):473-7. PubMed ID: 3802952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.
    Martínez MA; Ares I; Rodríguez JL; Martínez M; Martínez-Larrañaga MR; Isea G; Anadón A
    Front Vet Sci; 2017; 4():77. PubMed ID: 28596959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tissue distribution of progesterone-7-H3 in the female genital tract 8 hours after intravenous administration].
    Canales Pérez ES; Karchmer S; Merino G; Gallegos AJ
    Ginecol Obstet Mex; 1970 Apr; 27(162):397-407. PubMed ID: 4194000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antibiotic prophylaxis using a combination of pefloxacin and fosfomycin in heart surgery with CEC (extracorporeal circulation) in patients allergic to beta-lactams].
    Lebreton P; Vergnaud M; Zerr C; Nigam M; Kaladji C; Quesnel J
    Cah Anesthesiol; 1989; 37(2):77-87. PubMed ID: 2731058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antimicrobial prophylaxis in urologic endoscopic surgery: pefloxacin versus ceftriaxone].
    Osca García JM; Broseta Rico E; Ruiz Cerda JL; García Reboll L; Morera Martínez J; Martínez Jabaloyas JM; Jiménez Cruz JF
    Actas Urol Esp; 1993 Sep; 17(8):483-6. PubMed ID: 8237525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of rifampin on the pharmacokinetics of pefloxacin.
    Humbert G; Brumpt I; Montay G; Le Liboux A; Frydman A; Borsa-Lebas F; Moore N
    Clin Pharmacol Ther; 1991 Dec; 50(6):682-7. PubMed ID: 1752112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of ketoprofen on the pharmacokinetics of two fluoroquinolones in males].
    Leroy A; Fillastre JP; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Pathol Biol (Paris); 1993 Apr; 41(4):379-84. PubMed ID: 8233639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients.
    van de Leur JJ; Vollaard EJ; Janssen AJ; Dofferhoff AS
    Antimicrob Agents Chemother; 1995 May; 39(5):1182-4. PubMed ID: 7625811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.
    Dow J; Chazal J; Frydman AM; Janny P; Woehrle R; Djebbar F; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():81-7. PubMed ID: 3458700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography.
    Munera MI; Cuesta F; Abadia A; Vasquez J; Restrepo M
    Antimicrob Agents Chemother; 1994 Mar; 38(3):632-4. PubMed ID: 8203867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Penetration of ciprofloxacin into gynecologic tissues.
    Dalhoff A; Weuta H
    Am J Med; 1987 Apr; 82(4A):133-8. PubMed ID: 3555027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinico-pharmacologic studies on pefloxacin].
    Ludwig E; Székely E; Csiba A
    Orv Hetil; 1994 Mar; 135(13):687-92. PubMed ID: 8170669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of pefloxacin and amikacin administered simultaneously to patients undergoing resuscitation.
    Sultan E; Singlas E; Richard C; Auzepy P
    Chemioterapia; 1987 Jun; 6(2 Suppl):305-6. PubMed ID: 3509424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.